TAFASITAMAB

Tafasitamab 200 mg injection, 1 vial

TAFASITAMAB (15484Y)

Tafasitamab 200 mg injection, 1 vial
15484Y
Body System:
Manner of administration:Injection
Public
Chemotherapy Items for Public Hospital use
Authority Required

Restriction

Indication: Relapsed or refractory follicular lymphoma
Treatment phase: Continuing treatment (Cycles 6 - 12 inclusive)
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 1400 mg # of repeats: 13 DPMA: $8,352.21 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
MINJUVI
(Tafasitamab 200 mg injection, 1 vial)